ArticleScientific reports2025
Radiomics analysis based on T2-weighed imaging and T2 mapping for staging endometrial fibrosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insights into endometrial cancer management: a comprehensive guide through multimodality imaging.Abdominal radiology (New York) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Endometrial fibrosis can lead to uterine infertility. Accurate staging of endometrial fibrosis is crucial for developing treatment plans and performing dynamic follow-ups. This study aimed to evaluate the feasibility of radiomics models based on T2-weighed imaging (T2WI) and T2 mapping for staging endometrial fibrosis. This prospective study included 120 patients with severe endometrial fibrosis (SEF) and 50 patients with mild-moderate endometrial fibrosis (MMEF) confirmed by hysteroscopy, and 100 healthy controls (HC). Radiomic features were extracted from the volume of interest of endometrium on T2WI images and T2 maps to generate three models: T2WI, T2 mapping, and both T2WI and T2 mapping (merged). Feature importance selection was assessed with recursive feature elimination (RFE). Subsequently, logistic regression (LR), support vector machine (SVM), and decision tree (DT) were developed to determine the optimal radiomics models. Endometrial thickness (ET) and mean T2 value (Mean T2) were analyzed to construct ET+T2 model. The performance of the models was evaluated using receiver operating characteristic curve analysis and area under the curve (AUC). The merged radiomics model constructed by LR showed the highest performance with the macro and micro average AUC of 0.897 and 0.898, sensitivity of 0.744 and 0.873, specificity of 0.880 and 0.816, precision of 0.738 and 0.873, F1-score of 0.740 and 0.873, respectively. The LR-merged radiomics model had better classification performance [AUC (macro/micro), 0.897/0.898; overall accuracy, 0.765] than that of the ET+T2 model [AUC (macro/micro), 0.788/0.786; overall accuracy, 0.593]. Radiomics analysis based on T2WI and T2 mapping had the potential for the noninvasively staging endometrial fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.